A global collaborative teamed up to help diagnose rare lung disease with AI. Here’s how they did it

Already, the trio has learned a lot and run into challenges. Time to diagnosis can be more than three years, with one study estimating at least half of IPF patients are misdiagnosed once or more. No formal staging system exists to predict the progression of the disease in patients.

Together, along with input from 122 experts from fields including respiratory, radiology, neurology and machine learning, they are building out the Open Source Imaging Consortium Data Repository, a database of medical imaging...